Grants and Funding

What Are The Opportunities?

If you have an idea that could potentially advance medical knowledge or improve patients’ lives with BioPhoton Technology, learn more about the grants and funding FIAM may provide. You can download our detailed brochure for more information.

Examples of who may apply:

  • Physicians
  • Healthcare Providers
  • Scientists
  • Researchers
  • Medical Education Communication Companies
  • Medical Professional Organizations
  • Healthcare / Academic Institutions

What Types of Financial Support Does FIAM Provide?

We offer two main types of grants and funding opportunities:

Clinical Study Grants

Grants for Investigator-Initiated Studies may be offered to qualified physician, academic and community-based scientists, or consortia who want to propose and conduct clinical study independently.

The clinical study grants are to support clinical or health outcomes studies where FIAM is to contribute to the study by providing BioPhoton Generating devices.

These study-enabling grants are designed to potentially improve:

  • Treatment of disease
  • Patient outcomes
  • Quality of healthcare

3) BioPhoton Enabling Clinical Trials

BioPhoton enabling clinical trials are clinical research studies designed to test the effectiveness, safety, and potential benefits of BioPhoton-based technologies or therapies in a clinical setting. These trials focus on harnessing the properties of biophotons — to deliver medical treatments, diagnostics, or health outcomes.

These trials may be in device (BioPhoton Generators) or drug-device combination formats.

Potential Objectives of BioPhoton Enabling Clinical Trials:

  • Evaluate Efficacy: Determine the effectiveness of BioPhoton-based treatments or devices in improving health conditions or disease outcomes.
  • Assess Safety: Monitor and document any potential side effects or adverse reactions associated with BioPhoton technologies.
  • Optimize Dosage and Application: Establish the most effective methods, frequencies, and doses for applying BioPhoton treatments.
  • Compare with Standard Treatments: Compare the outcomes of BioPhoton-enabled therapies with traditional or existing treatments to assess relative benefits.
  • Explore Mechanisms: Investigate the biological mechanisms through which biophotons exert their effects on cells and tissues.

Potential Key Components of BioPhoton Enabling Clinical Trials:

  • Patient Recruitment: Selecting a diverse group of participants who meet specific inclusion criteria for the study.
  • Treatment Protocols: Defining how BioPhoton technology will be used, including the type of device, duration of exposure, and treatment frequency.
  • Outcome Measures: Identifying primary and secondary endpoints to measure the success of the intervention (e.g., symptom improvement, biomarker changes).
  • Data Collection and Analysis: Gathering and analyzing data to draw meaningful conclusions about the efficacy and safety of the BioPhoton-enabled treatment.
  • Regulatory Compliance: Ensuring the trial adheres to ethical standards, regulatory requirements, and good clinical practice guidelines.

Potential Benefits:

  • Innovative Treatments: Introducing new therapeutic options that leverage the unique properties of biophotons.
  • Improved Patient Outcomes: Enhancing the effectiveness of treatments and potentially reducing side effects.
  • Advancement of Science: Contributing to the scientific understanding of biophoton interactions with biological systems.

BioPhoton Enabling clinical trials are a crucial step in validating and optimizing the use of BioPhoton technology in medicine, ultimately aiming to bring innovative and effective treatments to patients.